/term/net-income-from-continuing-operations/ROCO:7575 AMED Co (ROCO:7575) Net Income From Continuing Operations
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AMED Co Ltd (ROCO:7575) » Definitions » Net Income From Continuing Operations

AMED Co (ROCO:7575) Net Income From Continuing Operations : NT$122.2 Mil (TTM As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is AMED Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. AMED Co's net income from continuing operations for the six months ended in Dec. 2023 was NT$73.5 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2023 was NT$122.2 Mil.


AMED Co Net Income From Continuing Operations Historical Data

The historical data trend for AMED Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AMED Co Net Income From Continuing Operations Chart

AMED Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
33.17 53.84 69.78 105.36 122.23

AMED Co Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only 40.19 41.01 64.35 48.74 73.49

AMED Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$122.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AMED Co (ROCO:7575) Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 14, Wuquan 7th Road, 4th Floor, Wugu District, New Taipei, TWN
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.

AMED Co (ROCO:7575) Headlines

No Headlines